AMBS News 08/10/2014 00:27:11 $AMBS If i were you Joboggi,

New Post Public Reply Private Reply Replies (0) Message Board
Jake13
AMBS News 08/10/2014 00:27:11 $AMBS
If i were you Joboggi, I would agree..... fast money. I will be the third party to hold your 1000 and sol's 1000 with me...
and in sep 1st will be 2700 because i will invest in some AMBS while am at it.
INVEST WHERE THE MIRACLE IS

lol, if they do a RS before Labor Day then the pps is automatically above .15 cents. If you are serious then you would not be whining about this.
Let me know before either the open on Monday or before Gerald's blog whichever comes first. We can send the money to an agreed upon third party to hold until either it closes above .15 or Labor Day.

The share price would have to go up almost 37% from Friday's close for me to even have a chance of winning.

You'd practically be stealing my money.

p.s. None of this crap about a split adjusted basis. Either take the bet as proposed or STFU.
I will think about it. It sounds like a good deal to me. Labor day is Sept 1st. It is Aug 9th. The pps is 11 cents and about to go down. It would have to be on a split adjusted basis, although, I do not think they can do a RS before that meeting.

I will think about it.
Quote:
"wonder how much money runners got for AMBS"


they'll be getting 3 hots & a cot soon enough:

I know its difficult - but stay up to date and informed - Bro.

*****************************************************************************************************************************************************

http://www.sec.gov/News/PressRelease/Detail/P...-FQHGP43Ng

SEC Charges 4 Promoters with Manipulating Marijuana-Related Stocks and Other Microcap Companies

The SEC’s complaint filed in federal court in Tacoma, Wash., charges the following individuals:

Mikhail Galas, a stock promoter who lives in Vancouver, Wash.

Alexander Hawatmeh, a member of Worthmore Investments LLC, which owns a stock promotion website called stockhaven.com. He formerly lived in Vancouver and currently resides in Lincoln City, Oregon.

Christopher Mrowca, a stock promoter who operates Money Runners Group LLC, which has an affiliated stock promotion website called MoneyRunnersGroup.com. He lives in Bradenton, Fla.

Tovy Pustovit, who owns a stock promotion website called Explosive Alerts. He also lives in Vancouver.


where is it written the ambs is increasing A/S? Plz advise.
Even so, I have no problem. So many people here diffuse info with no facts just to substantiate sell off. Any opportunity to get cheaper share price from management is welcome by me, not from naysayers or people with veiled agenda.. Please adivse..In GC and AMBS team I trust
I'll bet you $1,000 that the share prices closes above .15 between now and Labor Day.

Take the bet. I can use the extra $1,000.

Interesting week ahead.

p.s. I don't expect you to make the bet. I know I wouldn't.

Note: I'll make the same bet with anyone else before either the open on Monday or Gerald's next blog which ever comes first.
New shares mean it is almost 100% certain $AMBS will 1) spin-out Diagnostics division, 2) #LymPro partner is a whale, 3) NASDAQ in 4-6 month
yo Iam - you don't even know what the "proposed" AS increase is for....

do you even own stock here...

there was provision in the filing for a disproportional reverse split

comprende ?
That is true.
have to look it up again, on the way out the door right now. will check when I get back.

wonder how much money runners got for AMBS
I missed the MJFF reference, do you have a link for that? Ok, that was the Nov 9 2012 "correction." of the MANF pd data. ok, got it.
yeah but they are not going to sell them, according to the financials they had $875 in the bank at the end of last year and according to a poster here that claims AMBS has never been promoted it will have A 500 MILLION DOLLAR A YEAR OPPORTUNITY at the end of this year. so there ya go, proof that they are not going to need the extra billion. maybe I should do some research into how many time the A/S has been raised in the last few years. hummm
Companies release BAD NEWS after the close on Friday to soften the blow, which it usually doesn't if it is really bad like this one. But that is the best time to do it.

But they will never sell all of those shares, JUST LIKE THEY DID NOT SELL MOST OF THE LAST BILLION.
Dr. Commissiong has served as the Chief Scientific Officer and a Director of Amarantus since co-founding the company in 2008. Prior to Amarantus, Dr. Commissiong served as the CSO of Neurotrophics, Inc. and Prescient Neuropharma, Inc. Throughout his distinguished career, Dr. Commissiong has been focused on the discovery of novel neurotrophic factors for the treatment of neurodegenerative diseases as well as understanding the fundamental underlying biology of protoplasmic type-1 astrocytes that secrete neurotrophic factors. He was Chief of the Neural Transplantation Unit, NINDS-NIH, from 1989-94 where his research focused on identifying therapeutic approaches to spinal cord injury. Dr. Commissiong was Head of the Neurotrophic Factors Group, NINDS-NIH, from 1994-97 where he focused on developing technologies to systematically identify novel neurotrophic factors with applications for specific Central Nervous System disorders. He co-founded Prescient Neuropharma in 1999, and discovered MANF in 2003. MANF is currently in preclinical development for the treatment of Parkinson’s disease. The work pioneered by Dr. Commissiong has led to significant advancements in the field of astrocyte-neuron biology. Dr. Commissiong believes that a fundamental understanding of astrocyte-neuron interactions in the Central Nervous System will lead to a new generation of therapies to treat brain-related disorders.

Dr. Commissiong did his Postdoctoral work in the Lab Preclin Pharmac, NIMH-NIH, concentrating on the application of quadrupole mass spectrometry in the analysis of neurotransmitters. He holds a Ph.D. in Neurophysiology from the University of Southampton, an M.Sc. in Biochemical Pharmacology from the University of Southampton, and a B.S. in Biology and Chemistry from the University of the West Indies.
- See more at: http://www.thechairmansblog.com/amarantus-bio...Rb7nz.dpuf
Do I have that right, they are increasing the authorized shares to TWO billion? wow, NOT being listed has its REALLY BIG advantages, you get to print money and not tell anyone when you do it until the end of the quarter.

I firmly believe that AMBS will never need to sell those shares, UNLESS OF COURSE, they want to keep going as a company. oh.

Someone noted that they would have to increase the float if they were going to get the LPC money, because of the tanked pps. I guess that was a correct assertion.

The finance part is not my forte, but I can read, doubling the float when it was just diluted down to undrinkable iced tea, is well, less drinkable.

AMBS the cult stock. How much of the company is owned by institutions? Interesting study in human behavior.
$$$$$$$$$$ AMBS $$$$$$$$$$
company has come a long way from this post in 2012,

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CData Software: A Challenger in Data Integration

Updated Category News Views 133

CData Software Earns Challenger Status Here we are, folks. CData Software just snagged the 'Challenger' title in the 2026 Gartner® Magic Quadrant™ for Data Integration Tools. For the uninitiated, that's a feather in the cap for these data wizards, proving they've got real skin in the game when it comes to connecting the data dots across enterprise landscapes. It’s...

Continue Reading
Elite Academy Takes Bold Step in Ethical AI for Schools

Updated Category News Views 171

Pioneering New Fronts in Education with AI Elite Academic Academy, a stalwart in California's public charter school landscape, has just taken a significant stride forward by stepping into the EDSAFE AI Alliance District Policy Lab. The move, announced in early November 2026, sees Elite diving into the intricate world of artificial intelligence in education, with a pointed...

Continue Reading
ImmunoGenesis Showcases STING Agonist Progress at SITC

Updated Category News Views 113

STING Agonists: The Next Frontier in Glioblastoma Treatment? Out there in the weeds of immunotherapy, ImmunoGenesis is gearing up for its moment at the SITC 2026 Annual Meeting with its STING agonist, IMGS-203. The stakes are skyscraper-high as this novel treatment makes a play against recurrent glioblastoma (GBM)—one tough cookie in the realm of brain cancers....

Continue Reading
PropWallet: A Game Changer for Prop Firm Payouts?

Updated Category News Views 58

Change is Brewing in Boca Raton Well, folks, looks like PropAccount.com is shaking up the payout game with their latest brainchild, PropWallet. Launched on November 4, 2026, in sunny Boca Raton, they're setting the stage for a new way to handle payouts at prop trading firms. It's more than just another payout method; it's a ploy for keeping traders hooked and firms...

Continue Reading
Qfin Holdings Faces Class Action Over Stock Drop

Updated Category News Views 122

Qfin Holdings' Troubled Waters Look, when a stock tanks by nearly 19% overnight, it isn't because of some fluke. And that's precisely what's got Qfin Holdings, Inc. investors gritting their teeth and lawyers sharpening their pencils. Deep Dive into Allegations For those keeping score, we're talking about serious allegations here: between March 18, 2026, and August 25,...

Continue Reading
Aker Solutions Lands Big Role in Qatar Oil Upgrade

Updated Category News Views 88

Qatari Venture Beckons Aker Solutions Well, it's not every day you hear about a decades-old oil field getting a facelift, and yet here we are. Aker Solutions has received a nod of approval with a letter of award from PTSC Mechanical and Construction Limited Company (PTSC M&C). This gig is all about the Maydan Mahzam oil field way off the Qatari coast—a legacy site...

Continue Reading
VeriSilicon's GCNanoOptimaV Transforms Wearable Tech

Updated Category News Views 88

Revving Up Wearables with Next-Gen Graphics Well, folks, VeriSilicon's at it again, rolling out some cutting-edge technology in the form of their spanking new GCNanoOptimaV GPU IP. If you're scratching your head wondering what this means for your wrist-bound gadgets, hang tight—I'm about to spell it out. Architectural Innovations: Striking the Balance Here's the scoop...

Continue Reading
Lakefront Living: Steuben County's Twin Tales

Updated Category News Views 108

Here’s how it is: choosing a lakefront home in Steuben County, Indiana, ain't just about picking a place with a killer view. It’s like buying a lifestyle package and you’d better know what you’re getting. An article by Tony Isa, the go-to real estate guru in these parts, puts the spotlight on Lake James and Clear Lake—but what matters is how each might wrangle...

Continue Reading
American Bitcoin Sees 5% Hike in Satoshis Per Share

Updated Category News Views 60

Digging Deeper into American Bitcoin's Latest Results Out of the blue, American Bitcoin Corp. (NASDAQ:ABTC) has dropped its third-quarter 2026 financial results, and guess what? It's looking like they've struck gold—or should I say, digital gold. The Miami-based operation is all about stacking those Bitcoins, weaving them into their business model like a knitter with a...

Continue Reading
Young Storytellers Honored: Bridging Cultures Through Journalism

Updated Category News Views 47

Leaders of Tomorrow: Campus News Awards 2026 It's no small feat to look at a room full of young journalists and see the future of how stories will be told. But that's exactly what happened at the Campus News Awards 2026 in Shenzhen. Here, kids from Hong Kong, Macao, Taiwan, and Southeast Asia stood proudly with their certificates, ready to tackle the changing landscape of...

Continue Reading

Top 5 Most Recently Viewed Articles

Alliance Pharma's Recent Trading Disclosure Insights

Updated Category News Views 179

Recent Trading Disclosure by Alliance Pharma plc FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code Key Information (a) Name of exempt principal trader: Investec Bank plc (b) Name of offeror/offeree: Alliance Pharma plc

Continue Reading
Understanding Disclosure Trends with AXA Investment Managers

Updated Category News Views 179

Public Opening Position Disclosure by AXA Investment Managers AXA Investment Managers S.A. has made a significant disclosure styled as Form 8.3, which highlights the firm’s interests in Empiric Student Property plc. This document, often referred to within the financing and investment community, emphasizes transparency regarding ownership stakes in major entities. Key...

Continue Reading
New Diabetes Type 5 Announced Following Groundbreaking Research

Updated Category News Views 466

Recognition of Type 5 Diabetes: A New Era in Health Awareness Malnutrition-related diabetes has officially been acknowledged as a distinct type, termed type 5 diabetes. This recognition from the International Diabetes Federation signifies a significant advancement in understanding a disease that predominately impacts lean, malnourished young adults and teens in developing...

Continue Reading
OpenAI Launches o3: A Major Leap in AI Reasoning Models

Updated Category News Views 341

OpenAI Unveils Groundbreaking AI Model o3 Recently, OpenAI introduced its advanced reasoning model, o3, marking a significant development in artificial intelligence. This new model is touted as the successor to o1 and has generated considerable excitement in the tech community. OpenAI's focus on enhancing reasoning and coding abilities is evident in the latest offering,...

Continue Reading
Adaptimmune and Genentech Settle Agreement, Opening New Doors

Updated Category News Views 151

Adaptimmune and Genentech Settle Disputes Adaptimmune Therapeutics PLC (NASDAQ: ADAP) has officially reached a major settlement with Genentech Inc. and its parent company, F. Hoffmann-La Roche Ltd. This agreement resolves all disputes arising from their previous collaboration and marks an important milestone for Adaptimmune, particularly as the company emphasizes its...

Continue Reading